The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScancell Holdings Share News (SCLP)

Share Price Information for Scancell Holdings (SCLP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.30
Bid: 9.10
Ask: 9.50
Change: -0.63 (-6.60%)
Spread: 0.40 (4.396%)
Open: 9.55
High: 8.92
Low: 8.92
Prev. Close: 9.55
SCLP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK WINNERS & LOSERS: Miners Continue Run, Oil Companies Fall

Tue, 14th Oct 2014 11:09

LONDON (Alliance News) - The following stocks are amongst the biggest risers and fallers within the main London indices midday Tuesday.
-------
FTSE 100 WINNERS
-------
Rio Tinto, up 2.2%, Anglo American, up 1.7%, Glencore, up 1.2%, BHP Billiton, up 1.0%, and Fresnillo, up 0.9%. According to an analyst, the mining stocks are continuing the run that started Monday in the wake of positive Chinese export data which signalled some strength in the country's economy. China is responsible for a large portion of the demand for mining products, therefore a strong Chinese economy is seen as positive news for miners.

International Consolidated Airlines Group, up 0.5%. HSBC has raised the company to Overweight from Neutral with a price target increase to 400.00 pence from 380.00p. The stock currently trades at 325.70p.
-------
FTSE 100 LOSERS
-------
Burberry Group, down 4.1%. The British luxury fashion retailer said sales growth slowed in the second quarter as its key travelling Chinese consumers splurged out less on its clothes and leather goods, and it warned that weak consumer confidence in Europe and slower Asian growth would weigh on its second half. The company said revenue rose 14% on an underlying basis in the six months to September 30, to GBP1.1 billion, buoyed by 15% sales growth in retail revenue, and 13% growth in wholesale revenue. It said licensing revenue was down 3% on an underlying basis. On a reported basis, retail and wholesale sales were up only 8%, while licensing revenue was down 18%, which marked a slowdown from the first quarter when it had reported underlying sales growth of 17%, or 9% on a reported basis. Comparable retail sales growth in the first quarter was 12%, but slowed to 8% in the second quarter. Burberry said it now expects a smaller profit hit from currency moves than previously expected for the full financial year. It also warned of a "tougher macro environment" for the second half, but would not clarify what the more "difficult" environment for the remainder of the year would be.

Hargreaves Lansdown, down 2.9%. The investment management company reported a GBP100.0 million increase in assets under administration over the course of the traditionally quiet first quarter, but said levels of net new business were lower than in the corresponding period last year amid uncertainty over the Scottish independence referendum, concern over Middle East and Ukrainian conflicts and unfavourable Eurozone economic data. Hargreaves Lansdown reported GBP970.0 million of net new business inflows in the quarter ended September 30, compared with GBP1.26 billion in the corresponding quarter last year.

Tullow Oil, down 1.6%, BP, down 1.6%, and BG Group, down 1.4%. The companies are down after the price of Brent Oil fell to a near four-year low at USD87.55 a barrel on Tuesday morning.
-------
FTSE 250 WINNERS
-------
Bellway, up 3.4%. The UK housebuilder reported a jump in full-year profit as higher sales volumes at higher average prices lifted revenue by a third, and the company predicted further volume growth in the current year, albeit at a slower rate. The company reported a pretax profit of GBP245.9 million for the year to end-July, up from GBP140.9 million a year earlier, as revenue rose to GBP1.49 billion, from GBP1.11 billion. It also raised its total dividend to 52.0 pence, from 30.0 pence, on the back of the strong results, meaning it will have returned over GBP220 million to shareholders since 2007. The final dividend will be 36.0p, up from 21.0p. It said the total dividend is covered by earnings 3.0 times, a level it expects to maintain for the foreseeable future.

Afren, up 2.6%. The oil and gas explorer and producer confirmed that it has terminated the employment of Chief Executive Osman Shahenshah and Chief Operating Officer Shahid Ullah with immediate effect, firing them for gross misconduct based on evidence found by a review that unearthed irregular payments and starting legal proceedings to recover money from them. It also fired Associate Directors Iain Wright and Galib Virani with immediate effect for the same reasons, and started disciplinary action against seven more employees who it said also received payments.

Just Retirement Group, up 1.6%. The specialist insurer said it has completed its largest defined benefit de-risking transaction, a buy-in deal for GBP75 million which was contracted in September. In a statement, the company said it can't disclose the full details of the deal until all the scheme's members have been told the particulars, but it will provide a bulk annuity contract to the scheme trustees to cover all pensioner members and the deal marks it first completed transaction with the employee benefit consultant advising on the scheme.
-------
FTSE 250 LOSERS
-------
Michael Page International, down 10%. The recruitment company took a seven percentage point hit to its gross profit and said adverse currency movements will contribute to the group's operating profit growth coming in below market expectations. The company said its gross profit grew 11.6% on a constant currency basis in the quarter to September 30, with positive results coming from all four of its operating regions. On an actual currency basis, however, gross profit for the group increased only 4.7% as it was hit by the strength of sterling. Asia Pacific gross profit rose 2.9% to GBP28 million on an actual currency basis, up 11.1% on constant currency, while its Americas business posted a decline in its reported gross profit of 0.8% to GBP20 million, despite rising 9.6% on a constant currency basis.

Balfour Beatty, down 3.6%. The struggling engineering and construction company has issued a last-ditch warning to investors that failure to sell its American arm could result in it defaulting on its debts, The Daily Telegraph reported. In a circular posted to shareholders, the company revealed that it could breach its banking covenants in the coming months if the sell-off of Parsons Brinckerhoff is not approved, the newspaper said.

Ashmore Group, down 2.7%. The emerging markets asset manager reported a USD3.7 billion fall in assets under management over the course of the first quarter, citing negative investment performance of USD3.4 billion and net outflows of USD300 million. In a statement, the company said assets under management fell to USD71.3 billion at the end of September from USD75.0 billion at the end of June. Chief Executive Mark Coombs said the decline in assets under management over the quarter was primarily due to the "correction" in the markets towards the end of the period, driven by the strength of the US dollar.

Essentra, down 1.4%. The packaging components company has had its price target cut by three banks after Monday's trading update. Goldman Sachs has reduced its price to 970.00p from 1,000.00p keeping its Buy rating, JP Morgan cut its target price to 802.00p from 906.00p, with an Overweight rating, and Deutsche Bank cut its price to 840.00p from 920.00p with a Buy rating. The company currently trades at 688.00p.
-------
AIM ALL-SHARE WINNERS
-------
Global Energy Development, up 50%. The Latin America-focused petroleum explorer and producer has agreed to sell the rights and obligations of its contract areas within the Llanos Basin for USD50 million in cash to a subsidiary of TSX-listed oil and gas exploration company Platino Energy Corp. The company said it will use part of the proceeds to eliminate its its outstanding debt balance of USD7.5 million, and will decide what to do with the rest after the deal closes.

Allocate Software, up 34%. The company's board has recommended a takeover offer from an HgCapital Group takeover vehicle that would value the company at around GBP109.6 million. The vehicle has made an offer at 153.55 pence per share, which it said is a 35.3% increase on Allocate's closing price of 113.5 pence Monday. The acquisition is subject to approval from shareholders at the company's annual general meeting, and HGCapital has received acceptances for around 47.1% of Allocate's issued share capital. It needs at least 75% approval to pass. Allocate's board said that it considers the acquisition price to represent a "full and fair value to shareholders, providing certainty through the opportunity to realise value now for their current holdings in cash."

Solo Oil, up 14%. The company said it has signed a deal with Aminex to buy up to 13% of the Kiliwani North Development Licence in Tanzania. Solo said it would buy an initial 6.5% interest in the licence from Aminex-owned Ndovu Resources Ltd for USD3.5 million. The company also holds a 45-day option to increase its interest in the licence by a further 6.5% to 13%.

Scancell Holdings, up 9.6%. The company said it has seen positive results for its SCIB1 trials on a malignant melanoma treatment. Scancell said it has seen strong survival and safety data from the Phase 1 and 2 clinical trials conducted on SCIB1, its ImmunoBody platform vaccine. The results showed the product has the potential to become the first effective standalone treatment for adjuvant melanoma, it added. Adjuvant therapy is treatment provided in addition to the primary, main or initial treatment.
-------
AIM ALL-SHARE LOSERS
-------
Caledonia Mining, off 13%. The company said its earnings for the full year will be "materially lower" than current market expectations, after production fell at its Blanket Mine in Zimbabwe in its third quarter. Caledonia produced 9,890 ounces of gold at Blanket in the third quarter to end-September, down from 12,042 ounces in the previous year and 11,223 ounces in the previous quarter. The average head grade was lower than in previous quarter, and the tonnes mined and milled did not increase sufficiently to offset this, although plant recoveries have remained strong, Caledonia said. As a result, Caledonia lowered its gold production guidance for the year to 40,000 ounces from 45,000 ounces. It produced 31,354 ounces in the first nine months.

Immunodiagnostic Systems Holdings, down 13%. The company said it expects its revenue for the first half to be down on the previous year, as the near-term trading environment for its business "remains challenging." As it has previously flagged up in August and September, the company has seen a low level of placements, meaning instruments sold or leased to customers, and a faster decline in manual revenues, driven by lower 250H Vitamin D sales. This means it now expects revenues to GBP22 million in the first half to end-September, compared to GBP27 million a year before. Automated revenues fell by around 9% compared to the previous year as it saw number of instrument returns, and continued price pressure on its automated Vitamin D assay.

Mulberry Group, down 9.9%. The luxury bags, clothes and accessories maker gave a bleak outlook for the remainder of its financial year, after it said revenue in the first half fell 17% to GBP64.7 million, compared with GBP78.1 million the prior year, and warned its pretax profit for the full year to end of March 2015 will be "significantly below current expectations".
-------

By Neil Thakrar; neilthakrar@alliancenews.com

Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
26 Mar 2024 14:00

Scancell doses first patient in melanoma-focused trials

(Alliance News) - Scancell Holdings PLC announced on Tuesday that the first patient of a new trial cohort has been dosed with its iSCIB1+ therapeutic.

Read more
5 Feb 2024 14:09

TRADING UPDATES: Alliance Pharma appoints chair; FireAngel sales down

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
30 Jan 2024 13:56

Scancell interim loss narrows amid finance gain on derivative

(Alliance News) - Scancell Holdings PLC on Tuesday reported a narrowed loss as it gained on the revaluation of derivative liability.

Read more
17 Jan 2024 14:26

IN BRIEF: Scancell approved by MHRA to add new cohort to Scope trial

Scancell Holdings PLC - Oxford, England-based developer of immunotherapies for treatment of cancer and infectious disease said - Receives approval from UK's Medicines & Healthcare products Regulatory agency to add a third cohort to the Scope trial. Says the cohort will consist of 43 melanoma patients who will receive iSCIB1+ with doublet therapy, consisting of ipilimumab, under the brand name Yervoy, plus nivolumab, under the name Opdivo. "Exceptional" results from the first 13 patients receiving SCIB1 in the ongoing Scope trial, with an objective response rate of 85%, indicate a high probability of success in this cohort, which is expected to complete in the second quarter of 2024. Meanwhile, recruitment into the iSCIB1+ cohort is expected to be complete by the end of the second quarter as well, with early data expected in the third quarter of 2024.

Read more
19 Dec 2023 13:35

Scancell raises GBP12 million in total from fundraise

(Alliance News) - Scancell Holdings PLC on Tuesday said it has raised GBP11.9 million in total, from an open offer, placing, and subscription of shares.

Read more
1 Dec 2023 09:54

IN BRIEF: Scancell raises GBP10.7 million in upsized share sale

Scancell Holdings PLC - Oxford, England-based developer of immunotherapies for treatment of cancer and infectious disease - Raises GBP10.7 million from the placing and subscription of 97.0 million new shares at 11 pence each. The placing is run by Stifel Nicolaus Europe Ltd and WG Partners LLP. Scancell also plans an open offer of shares at the same price to raise up to another GBP2.0 million. Scancell says the placing was oversubscribed and upsized as a result. After the London market close on Thursday, Scancell had announced plans to raise just GBP6 million in the placing. It says the raise was led by "new institutional and life science specialist investors".

Read more
30 Nov 2023 21:10

EARNINGS AND TRADING: Dispensa and SkinBioTherapeutics losses widen

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
28 Nov 2023 14:57

TRADING UPDATES: Scancell trial progresses; OptiBiotix inks new deal

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
22 Nov 2023 15:53

UK shareholder meetings calendar - next 7 days

Thursday 23 November 
abrdn UK Smaller Companies Growth Trust PLCAGM
Avation PLCAGM
Bradda Head Lithium LtdAGM
DX Group PLCAGM
Europa Oil & Gas Holdings PLCAGM
Fiske PLCAGM
JPMorgan UK Smaller Cos Investment Trust PLCAGM
Hotel Chocolat Group PLCAGM
Pacific Horizon Investment Trust PLCAGM
Pan African Resources PLCAGM
PZ Cussons PLCAGM
Rosslyn Data Technologies PLCAGM
Friday 24 November 
Base Resources LtdAGM
Cloudbreak Discovery PLCAGM
Esken LtdEGM re Esken Renewables disposal
Neometals LtdAGM
Sovereign Metals LtdAGM
Sylvania Platinum LtdAGM
Monday 27 November 
Chelverton Growth Trust PLCGM re voluntary liquidation
European Smaller Cos Trust PLCAGM
JPMorgan Global Emerging Markets Income Trust PLCAGM
Quadrise PLCAGM
Tribal Group PLCGM re cash offer by Tiger Bidco 1 Ltd
Tuesday 28 November 
Bluefield Solar Income Fund LtdAGM
London Finance & Investment Group PLCAGM
Nanoco Group PLCAGM
Oakley Capital Investments LtdAGM
Wednesday 29 November 
Artemis Resources LtdAGM
Aura Energy LtdAGM
Contango Holdings PLCAGM
CVS Group PLCAGM
Fidelity Asian Values PLCAGM
Ikigai Ventures LtdAGM
Panthera Resources PLCAGM
Reconstruction Capital II LtdAGM
Renishaw PLCAGM
RiverFort Global Opportunities PLCAGM
Sabien Technology Group PLCAGM
Scancell Holdings PLCAGM
Seeing Machines LtdAGM
SLF Realisation Fund LtdAGM
Target Healthcare REIT PLCAGM
Thor Energy PLCAGM
Transense Technologies PLCAGM
Vast Resources PLCAGM
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
10 Nov 2023 11:14

IN BRIEF: Scancell shares up as presents "trailblazing" trial data

Scancell Holdings PLC - Nottingham, England-based cancer immunotherapies developer - Presents data from first stage of Phase 2 Scope trial at 20th International Congress of the Society for Melanoma Research on Thursday. Trial investigates Scancell's SCIB1 vaccination combined with checkpoint inhibitors in advanced melanoma. Company reported mid-September that SCIB1 combined with CPIs showed an 82% objective response rate. Scope trial is currently in its second stage. Scancell says on Friday that in Cohort 1 nine responses were achieved earlier than expected, and probability of second-stage success is around 90% based on current data.

Read more
31 Oct 2023 14:45

EARNINGS: Frontier IP chair to step down; "busy" Rosslyn narrows loss

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
20 Oct 2023 09:00

IN BRIEF: Scancell says needs more time to publish annual results

Scancell Holdings PLC - Nottingham, England-based cancer immunotherapies developer - Says auditor request additional time to complete standard audit of its results of financial year 2023 that ended on April 30. Cites unforeseen circumstances impacting the audit engagement team. Says audit is substantially complete without any material audit issues.

Read more
17 Oct 2023 15:43

UK earnings, trading statements calendar - next 7 days

Wednesday 18 October 
888 Holdings PLCTrading Statement
Antofagasta PLCTrading Statement
BHP Group LtdTrading Statement
Cirata PLCTrading Statement
Hochschild Mining PLCTrading Statement
Liontrust Asset Management PLCTrading Statement
Quilter PLCTrading Statement
Segro PLCTrading Statement
Sosandar PLCTrading Statement
Whitbread PLCHalf Year Results
Thursday 19 October 
AJ Bell PLCTrading Statement
Centamin PLCQ3 Results
Deliveroo PLCTrading Statement
Dunelm Group PLCTrading Statement
GB Group PLCTrading Statement
Gear4Music PLCHalf Year Results
Hargreaves Lansdown PLCTrading Statement
London Stock Exchange Group PLCTrading Statement
Man Group PLCTrading Statement
Mondi PLCTrading Statement
PensionBee Group PLCTrading Statement
Rathbones Group PLCTrading Statement
Relx PLCTrading Statement
Rentokil Initial PLCQ3 Results
Sabre Insurance Group PLCTrading Statement
Schroders PLCTrading Statement
St James's Place PLCTrading Statement
Friday 20 October 
Foxtons Group PLCTrading Statement
InterContinental Hotels Group PLCTrading Statement
Record PLCTrading Statement
Monday 23 October 
Shanta Gold LtdTrading Statement
South32 LtdTrading Statement
Tuesday 24 October 
Angling Direct PLCHalf Year Results
Anglo American PLCTrading Statement
Barclays PLCQ3 Results
Bunzl PLCTrading Statement
FD Technologies PLCHalf Year Results
Gattaca PLCFull Year Results
Petra Diamonds LtdQ1 Results
Scancell Holdings PLCFull Year Results
Softcat PLCFull Year Results
Travis Perkins PLCTrading Statement
Trifast PLCTrading Statement
WAG Payment Solutions PLCTrading Statement
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
22 Sep 2023 13:05

IN BRIEF: Oxford Technology 2 VCT asset value hurt by AIM share falls

Oxford Technology 2 VCT PLC - venture capital trust investing in quoted and unquoted technology companies - Net asset value of OT1 shares falls by 16% to 37.9 pence on August 31 from 45.3p on February 28. Similarly, NAV of OT2 shares falls to 20.5p from 25.1p, of OT3 shares to 23.6p from 33.7p, and of OT4 shares to 25.4p from 29.7p. No dividends are paid during the half year, nor are any shares bought back.

Read more
19 Sep 2023 14:32

Scancell celebrates "positive" clinical trial data for cancer vaccine

(Alliance News) - Scancell Holdings PLC shares surged on Tuesday after the company announced positive results from the phase 2 clinical trial of its SCIB1 treatment for advanced melanoma.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.